214 related articles for article (PubMed ID: 21954225)
1. Akt activation is responsible for enhanced migratory and invasive behavior of arsenic-transformed human bronchial epithelial cells.
Wang Z; Yang J; Fisher T; Xiao H; Jiang Y; Yang C
Environ Health Perspect; 2012 Jan; 120(1):92-7. PubMed ID: 21954225
[TBL] [Abstract][Full Text] [Related]
2. Src promotes EGF-induced epithelial-to-mesenchymal transition and migration in gastric cancer cells by upregulating ZEB1 and ZEB2 through AKT.
Zhao L; Li X; Song N; Li A; Hou K; Qu X; Che X; Liu Y
Cell Biol Int; 2018 Mar; 42(3):294-302. PubMed ID: 29052277
[TBL] [Abstract][Full Text] [Related]
3. Reversal and prevention of arsenic-induced human bronchial epithelial cell malignant transformation by microRNA-200b.
Wang Z; Zhao Y; Smith E; Goodall GJ; Drew PA; Brabletz T; Yang C
Toxicol Sci; 2011 May; 121(1):110-22. PubMed ID: 21292642
[TBL] [Abstract][Full Text] [Related]
4. UBE2C, Directly Targeted by miR-548e-5p, Increases the Cellular Growth and Invasive Abilities of Cancer Cells Interacting with the EMT Marker Protein Zinc Finger E-box Binding Homeobox 1/2 in NSCLC.
Jin D; Guo J; Wu Y; Du J; Wang X; An J; Hu B; Kong L; Di W; Wang W
Theranostics; 2019; 9(7):2036-2055. PubMed ID: 31037155
[No Abstract] [Full Text] [Related]
5. MiR-10b Directly Targets ZEB1 and PIK3CA to Curb Adenomyotic Epithelial Cell Invasiveness via Upregulation of E-Cadherin and Inhibition of Akt Phosphorylation.
Guo Y; Lang X; Lu Z; Wang J; Li T; Liao Y; Jia C; Zhao W; Fang H
Cell Physiol Biochem; 2015; 35(6):2169-80. PubMed ID: 25896413
[TBL] [Abstract][Full Text] [Related]
6. Fra-1/AP-1 induces EMT in mammary epithelial cells by modulating Zeb1/2 and TGFβ expression.
Bakiri L; Macho-Maschler S; Custic I; Niemiec J; Guío-Carrión A; Hasenfuss SC; Eger A; Müller M; Beug H; Wagner EF
Cell Death Differ; 2015 Feb; 22(2):336-50. PubMed ID: 25301070
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-200b regulates cell proliferation, invasion, and migration by directly targeting ZEB2 in gastric carcinoma.
Kurashige J; Kamohara H; Watanabe M; Hiyoshi Y; Iwatsuki M; Tanaka Y; Kinoshita K; Saito S; Baba Y; Baba H
Ann Surg Oncol; 2012 Jul; 19 Suppl 3():S656-64. PubMed ID: 22311119
[TBL] [Abstract][Full Text] [Related]
8. Restin suppressed epithelial-mesenchymal transition and tumor metastasis in breast cancer cells through upregulating mir-200a/b expression via association with p73.
Lu Z; Jiao D; Qiao J; Yang S; Yan M; Cui S; Liu Z
Mol Cancer; 2015 May; 14():102. PubMed ID: 25972084
[TBL] [Abstract][Full Text] [Related]
9. Long non-coding RNA urothelial cancer-associated 1 promotes bladder cancer cell migration and invasion by way of the hsa-miR-145-ZEB1/2-FSCN1 pathway.
Xue M; Pang H; Li X; Li H; Pan J; Chen W
Cancer Sci; 2016 Jan; 107(1):18-27. PubMed ID: 26544536
[TBL] [Abstract][Full Text] [Related]
10. miR-139-5p inhibits epithelial-mesenchymal transition, migration and invasion of hepatocellular carcinoma cells by targeting ZEB1 and ZEB2.
Qiu G; Lin Y; Zhang H; Wu D
Biochem Biophys Res Commun; 2015 Jul; 463(3):315-21. PubMed ID: 26022123
[TBL] [Abstract][Full Text] [Related]
11. Epithelial to mesenchymal transition in arsenic-transformed cells promotes angiogenesis through activating β-catenin-vascular endothelial growth factor pathway.
Wang Z; Humphries B; Xiao H; Jiang Y; Yang C
Toxicol Appl Pharmacol; 2013 Aug; 271(1):20-9. PubMed ID: 23643801
[TBL] [Abstract][Full Text] [Related]
12. Loss of miR-200b promotes invasion via activating the Kindlin-2/integrin β1/AKT pathway in esophageal squamous cell carcinoma: An E-cadherin-independent mechanism.
Zhang HF; Alshareef A; Wu C; Li S; Jiao JW; Cao HH; Lai R; Xu LY; Li EM
Oncotarget; 2015 Oct; 6(30):28949-60. PubMed ID: 26334393
[TBL] [Abstract][Full Text] [Related]
13. Involvement of LKB1 in epithelial-mesenchymal transition (EMT) of human lung cancer cells.
Roy BC; Kohno T; Iwakawa R; Moriguchi T; Kiyono T; Morishita K; Sanchez-Cespedes M; Akiyama T; Yokota J
Lung Cancer; 2010 Nov; 70(2):136-45. PubMed ID: 20207041
[TBL] [Abstract][Full Text] [Related]
14. Phosphoglucose isomerase/autocrine motility factor mediates epithelial-mesenchymal transition regulated by miR-200 in breast cancer cells.
Ahmad A; Aboukameel A; Kong D; Wang Z; Sethi S; Chen W; Sarkar FH; Raz A
Cancer Res; 2011 May; 71(9):3400-9. PubMed ID: 21389093
[TBL] [Abstract][Full Text] [Related]
15. Targeting FoxM1 inhibits proliferation, invasion and migration of nasopharyngeal carcinoma through the epithelial‑to-mesenchymal transition pathway.
Yu C; Chen L; Yie L; Wei L; Wen T; Liu Y; Chen H
Oncol Rep; 2015 May; 33(5):2402-10. PubMed ID: 25738652
[TBL] [Abstract][Full Text] [Related]
16. ZEB2 mediates multiple pathways regulating cell proliferation, migration, invasion, and apoptosis in glioma.
Qi S; Song Y; Peng Y; Wang H; Long H; Yu X; Li Z; Fang L; Wu A; Luo W; Zhen Y; Zhou Y; Chen Y; Mai C; Liu Z; Fang W
PLoS One; 2012; 7(6):e38842. PubMed ID: 22761708
[TBL] [Abstract][Full Text] [Related]
17. Epidermal growth factor receptor and mutant p53 expand an esophageal cellular subpopulation capable of epithelial-to-mesenchymal transition through ZEB transcription factors.
Ohashi S; Natsuizaka M; Wong GS; Michaylira CZ; Grugan KD; Stairs DB; Kalabis J; Vega ME; Kalman RA; Nakagawa M; Klein-Szanto AJ; Herlyn M; Diehl JA; Rustgi AK; Nakagawa H
Cancer Res; 2010 May; 70(10):4174-84. PubMed ID: 20424117
[TBL] [Abstract][Full Text] [Related]
18. The miR-200 family inhibits epithelial-mesenchymal transition and cancer cell migration by direct targeting of E-cadherin transcriptional repressors ZEB1 and ZEB2.
Korpal M; Lee ES; Hu G; Kang Y
J Biol Chem; 2008 May; 283(22):14910-4. PubMed ID: 18411277
[TBL] [Abstract][Full Text] [Related]
19. Zinc finger E-box binding homeobox 1 promotes invasion and bone metastasis of small cell lung cancer in vitro and in vivo.
Liu Y; Zhang N; Wang Y; Xu M; Liu N; Pang X; Cao J; Ma N; Pang H; Liu L; Zhang H
Cancer Sci; 2012 Aug; 103(8):1420-8. PubMed ID: 22632166
[TBL] [Abstract][Full Text] [Related]
20. miR-139-5p suppresses cancer cell migration and invasion through targeting ZEB1 and ZEB2 in GBM.
Yue S; Wang L; Zhang H; Min Y; Lou Y; Sun H; Jiang Y; Zhang W; Liang A; Guo Y; Chen P; Lv G; Wang L; Zong Q; Li Y
Tumour Biol; 2015 Sep; 36(9):6741-9. PubMed ID: 25833697
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
